Your session is about to expire
← Back to Search
Treatment for Prostate Cancer
N/A
Recruiting
Led By Aadel Chaudhuri, M.D., Ph.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Eligible healthy donors will be at least 18 years of age.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion of study (estimated to be 6.5 years)
Awards & highlights
Summary
This trial has the potential to improve patient outcomes by detecting disease recurrence earlier and offering greater treatment options.
Eligible Conditions
- Prostate Cancer
- Colon Cancer
- Cancer
- Gastrointestinal Cancer
- Head and Neck Cancers
- Healthy Subjects
- Genitourinary Cancers
- Skin Cancer
- Sarcoma
- Breast Cancer
- Lung Cancer
- Melanoma
- Esophageal Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through completion of study (estimated to be 6.5 years)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion of study (estimated to be 6.5 years)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Freedom from progression
Secondary outcome measures
Disease-specific survival
Distant-metastasis-free survival
Event-free survival
+2 moreFind a Location
Who is running the clinical trial?
National Center for Advancing Translational Science (NCATS)NIH
99 Previous Clinical Trials
36,171 Total Patients Enrolled
Roche Sequencing SolutionsIndustry Sponsor
2 Previous Clinical Trials
22,955 Total Patients Enrolled
The V Foundation for Cancer ResearchOTHER
19 Previous Clinical Trials
1,197 Total Patients Enrolled
1 Trials studying Prostate Cancer
9 Patients Enrolled for Prostate Cancer
Share this study with friends
Copy Link
Messenger